Few areas of medicine have been as controversial and emotionally charged as breast cancer screening. Although mammography screening is a mainstay of preventive health care for women in the United States, the limitations of mammography for detecting breast cancer among women with mammographically dense breasts have received increasing attention from both advocacy groups and the medical community. Currently, legislation addressing communication regarding breast density is in place for a majority of states (38 states and the District of Columbia), and a federal law mandates that the US Food and Drug Administration advance minimum national standards for breast density reporting to women undergoing mammography screening through changes to Mammography Quality Standards Act regulations.1
Tosteson ANA. An Abbreviated MRI Protocol for Breast Cancer Screening in Women With Dense Breasts: Promising Results, but Further Evaluation Required Prior to Widespread Implementation. JAMA. 2020;323(8):719–721. doi:10.1001/jama.2020.0357
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: